ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03518047
Brief Title: Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation (IMMPRESS)

First Submitted : May 4, 2018
First Submitted that Met QC Criteria : May 4, 2018
First Posted : May 8, 2018

Last Update Submitted that Met QC Criteria : December 21, 2018
Last Update Posted : December 24, 2018